BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38673919)

  • 1. D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study.
    Szmyd B; Stanisławska P; Podstawka M; Zaczkowski K; Izbiński PM; Kulczycka-Wojdala D; Stawski R; Wiśniewski K; Janczar K; Braun M; Białasiewicz P; Jaskólski DJ; Bobeff EJ
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
    Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
    Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association of MDM2 SNP309 with risk of glioblastoma and prognosis.
    El Hallani S; Marie Y; Idbaih A; Rodero M; Boisselier B; Laigle-Donadey F; Ducray F; Delattre JY; Sanson M
    J Neurooncol; 2007 Dec; 85(3):241-4. PubMed ID: 17568997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
    Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
    J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study.
    Pinson H; Hallaert G; Van der Meulen J; Dedeurwaerdere F; Vanhauwaert D; Van den Broecke C; Van Dorpe J; Van Roost D; Kalala JP; Boterberg T
    J Neurooncol; 2020 Jan; 146(1):55-62. PubMed ID: 31701343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
    Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
    J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low mitochondrial DNA copy number is associated with poor prognosis and treatment resistance in glioblastoma.
    Sravya P; Nimbalkar VP; Kanuri NN; Sugur H; Verma BK; Kundu P; Rao S; Uday Krishna AS; Somanna S; Kondaiah P; Arivazhagan A; Santosh V
    Mitochondrion; 2020 Nov; 55():154-163. PubMed ID: 33045388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR amplification is a real independent prognostic impact factor between young adults and adults over 45yo with wild-type glioblastoma?
    Armocida D; Pesce A; Frati A; Santoro A; Salvati M
    J Neurooncol; 2020 Jan; 146(2):275-284. PubMed ID: 31889239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma.
    Skiriutė D; Vaitkienė P; Ašmonienė V; Steponaitis G; Deltuva VP; Tamašauskas A
    J Neurooncol; 2013 Jul; 113(3):441-9. PubMed ID: 23624749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy number.
    Marucci G; Maresca A; Caporali L; Farnedi A; Betts CM; Morandi L; de Biase D; Cerasoli S; Foschini MP; Bonora E; Vidone M; Romeo G; Perli E; Giordano C; d'Amati G; Gasparre G; Baruzzi A; Carelli V; Eusebi V
    Hum Pathol; 2013 Sep; 44(9):1867-76. PubMed ID: 23664543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated Hsp27 is mutually exclusive with ATRX loss and the IDH1
    Cai HQ; Wang PF; Zhang HP; Cheng ZJ; Li SW; He J; Zhang Y; Hao JJ; Wang MR; Yan CX; Wan JH
    J Clin Pathol; 2018 Aug; 71(8):702-707. PubMed ID: 29550762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
    Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T
    Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.
    Wang K; Wang YY; Ma J; Wang JF; Li SW; Jiang T; Dai JP
    Asian Pac J Cancer Prev; 2014; 15(24):10893-8. PubMed ID: 25605197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic Mitochondrial Mutations in Oral Cavity Cancers among Senegalese Patients.
    Toure S; Mbaye F; Gueye MD; Fall M; Dem A; Lamy JB; Sembene M
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2203-2208. PubMed ID: 31350985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.
    Tomoszková S; Škarda J; Lipina R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.
    Wang S; Liu F; Wang Y; Fan W; Zhao H; Liu L; Cen C; Jiang X; Sun M; Han P
    J Transl Med; 2019 May; 17(1):179. PubMed ID: 31138312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional prediction of mitochondrial complex III and IV mutations associated with glioblastoma.
    Lloyd RE; Keatley K; Littlewood DT; Meunier B; Holt WV; An Q; Higgins SC; Polyzoidis S; Stephenson KF; Ashkan K; Fillmore HL; Pilkington GJ; McGeehan JE
    Neuro Oncol; 2015 Jul; 17(7):942-52. PubMed ID: 25731774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of mitochondrial DNA copy number in glioblastoma cells.
    Dickinson A; Yeung KY; Donoghue J; Baker MJ; Kelly RD; McKenzie M; Johns TG; St John JC
    Cell Death Differ; 2013 Dec; 20(12):1644-53. PubMed ID: 23995230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.
    Shin JH; Lee YS; Hong YK; Kang CS
    J Neurooncol; 2013 Dec; 115(3):333-41. PubMed ID: 24129546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.